Association of proteinuria with various clinical findings and morphologic variables of Oxford classification in immunoglobulin A nephropathy patients

International Journal of Preventive Medicine

Volumn 4, Issue 5, 2013, Pages 546-551

  Nasri, Hamid ^a   Madihi, Yahya ^b,c   Merrikhi, Alireza ^b,c   Gheissari, Allaleh ^b,c   Baradaran, Azar ^a   Kheiri, Soleiman ^d   Rafieian Kopaei, Mahmoud ^d  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Crescent; Immunoglobulin A nephropathy; Nephrotic syndrome; Oxford classification; Proteinuria

Indexed keywords

CREATININE;

ADULT; ARTICLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FIBROSIS; KIDNEY STRUCTURE; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; OBSERVATIONAL STUDY; PROGNOSIS; PROTEINURIA;

EID: 84879573973     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Chandrika BK. IgA nephropathy in Kerala, India: A retrospective study. Indian J Pathol Microbiol 2009;52:14-6.
2. Solati M, Mahboobi HR. Paraoxonase enzyme activity and dyslipidemia in chronic renal failure patients. J Nephropathology 2012;1:123-5.
3. Mubarak M. Oxford classification of IgA nephropathy: Broadening the scope of the classification. J Nephropathology 2012;1:13-6.
4. Julian BA, Waldo FB, Rifai A, Mesteckey J. IgA nephropathy, the most common glomerulonephritis worldwide: A neglected disease in the United States? Am J Med 1988;84:129-32.
5. Nasri H, Mortazavi M, Ghorbani A, Shahbazian H, Kheiri S, Baradaran A, et al. Oxford-MEST classification in IgA nephropathy patients: A report from Iran. J Nephropathology 2012;1:31-42.
6. Kim SM, Moon KC, Oh KH, Kwon Joo KW, Kim YS, Ahn C, et al. Clinicopathologic characteristics of IgA nephropathy with steroid-responsive nephrotic syndrome. J Korean Med Sci 2009;24:S44-9.
7. Assadi F. The epidemic of pediatric chronic kidney disease the danger of skepticism. J Nephropathology 2012;1:61-4.
8. Sahni N, Gupta KL. Dietary antioxidents and oxidative stress in predialysis chronic kidney patients. J Nephropathology 2012;1:134-42.
9. Mubarak M. The prevalence of IgA nephropathy in Pakistan: Only a tip of the iceberg. J Pak Med Assoc 2009;59:733.
10. Tayebi Khosroshahi H. Short history about renal transplantation program in Iran and the world: Special focus on world kidney day 2012. J Nephropathology 2012;1:5-10.
11. Mubarak M. IgA nephropathy: An update on pathogenesis and classification. J Coll Physicians Surg Pak 2011;21:230-3.
12. Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant 2002;17:1197-203.
13. Nasri H. Hypertension and renal failure with right arm pulse weakness in a 65 years old man. J Nephropathology 2012;1:130-3.
14. Kobayashi Y, Hiki Y, Sano T, Hashizume K, Matsuo T, Nakamura I, et al. Prognostic significance of persistent massive proteinuria in IgA nephropathy: 10-year follow-up study of 366 cases. Nephrology 2001;6:A23-4.
15. D'Amico G. The most commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709-27.
16. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study. Am J Kidney Dis 2000;35:157-65.
17. Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. research group on progressive renal diseases. Am J Kidney Dis 1997;29:526-32.
18. Berthoux FC, Mohey H, Afiani A. Natural history of primary IgA nephropathy. Semin Nephrol 2008;28:4-9.
19. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004;24:179-96.
20. Lv JC, Zhang H, Zhou Y, Li GT, Zou WZ, Wang HY. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: A long-term follow up of 204 cases in China. Nephrology (Carlton) 2008;13:242-6.
21. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses. Am J Kidney Dis 1991;18:12-9.
22. D'Amico G. Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am J Kidney Dis 2000;35:157-65.
23. Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001;38:728-35.
24. Woo KT, Lau YK, Wong KS, Chiang GS. ACEI/ ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis. Kidney Int 2000;58:2485-91.
25. Praga M, Gutiérrez E, González E, Morales E, Hernández E. Treatment of IgA nephropathy with ACE inhibitors: A randomized and controlled trial. J Am Soc Nephrol 2003;14:1578-83.
26. Dillon JJ. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy. Semin Nephrol 2004;24:218-24.
27. Ballardie FW, Cowley RD. Prognostic indices and therapy in IgA nephropathy: Toward a solution. Kidney Int 2008;73:249-51.
28. Barratt J, Feehally J. IgA Nephropathy. J Am Soc Nephrol 2005;16:2088-97.
29. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, et al. The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification. Kidney Int 2009;76:534-45.
30. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int 2010;77:921-7.
31. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, et al. The Oxford classification of IgA nephropathy: Pathology definitions, correlations, and reproducibility. Kidney Int 2009;76:546-56.
32. Mubarak M, Kazi JI, Kulsoom U, Ishaque M. Detection of immunoglobulins and complement components in formalin fixed and paraffin embedded renal biopsy material by immunoflourescence technique. J Nephropathology 2012;1:91-100.
33. Mubarak M. Collapsing focal segmental glomerulosclerosis: Increasing the awareness. J Nephropathology 2012;1:77-80.
34. Mohammadi Torbati P. Focal segmental glomerulosclerosis; collapsing variant. J Nephropathology 2012;1:87-90.
35. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int 2010;77:921-7.
36. Karimifar M. Deep vein thrombosis in combination with granulomatosis with polyangiitis (Wegener's). J Nephropathology 2012;1:57-8.
37. Tolou-Ghamari Z., Neurotoxicity, mechanisms of rejection: A review on Tacrolimus and Cyclosporin in organ transplantation. J Nephropathology 2012;1:23-30.
38. Ardalan MR, Samadifar Z, Vahedi A. Creatine monohydrate supplement induced interstitial nephritis. J Nephropathology 2012;1:117-20.
39. Gheissari A, Mehrasa P, Merrikhi A, Madihi Y. Acute kidney injury: A pediatric experience over 10 years at a tertiary care center. J Nephropathology 2012;1:101-8.
40. Mortazavi M, Nasri H. Granulomatosis with polyangiitis (Wegener's) presenting as the right ventricular masses: A case report and review of the literature. J Nephropathology 2012;1:49-56.
41. Galesic K, Ljubanovic D, Horvatic I. Treatment of renal manifestations of ANCA-associated vasculitis. J Nephropathology 2013;2:6-19.
42. Shakeel Sh, Mubarak M, Kazi JI, Jafry N, Ahmed E. Frequency and clinicopathological characteristics of variants of primary focal segmental glomerulosclerosis in adults presenting with nephrotic syndrome. J Nephropathology 2013;2:28-35.
43. Seif EI, Ibrahim EA, Elhefnawy NG, Salman MI. Histological patterns of idiopathic steroid resistant nephrotic syndrome in Egyptian children: A single centre study. J Nephropathology 2013;2:53-60.
44. Vanikar A. IgM nephropathy; can we still ignore it. J Nephropathology 2013;2:98-103.
45. Grcevska L, Ristovska V, Nikolov V, Petrusevska G, Milovanceva-Popovska M, Polenakovic M. The Oxford classification of IgA nephropathy: Single centre experience. Prilozi 2010;31:7-16.
46. Hwang HS, Kim BS, Shin YS, Yoon HE, Song JC, Choi BS, et al. Predictors for progression in Immunoglobulin A nephropathy with significant proteinuria. Nephrology (Carlton) 2010;15:236-41.
47. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathology 2012;1:162-3.
48. Rahimi Z. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. J Nephropathology 2012;1:143-51.
49. Gheissari A, Attarzadeh H, Sharif H, Pourhossein M, Merrikhi A. Steroid dependent and independent ocular findings in Iranian children with nephrotic syndrome. Int J Prev Med 2011;2:264-8.
50. Kam-Taoli PK, Burdmann EA, Mehta RL. Acute kidney injury: Global health alert. J Nephropathology 2013;2:90-7.
51. Gheissari A, Hemmatzadeh S, Merrikhi A, Fadaei Tehrani S, Madihi Y. Chronic kidney disease in children: Report from a tertiary care center over 11 years. J Nephropathology 2012;1:177-82.
52. Sánchez-Niño MD, Ortiz A. Is it or is it not a pathogenic mutation? Is it or is it not the podocyte? J Nephropathology 2012;1:152-4.
53. Maghsoudi AR, Baradaran-Ghahfarokhi M, Ghaed-Amini F, Nasri H, Mobarakeh MD, Rafieian-Kopaei M. Renal failure and submental lymphadenopathy in a 68 years old woman. J Nephropathology 2012;1:198-201.
54. Nasri H. Sudden onset of acute renal failure requiring dialysis associated with large B-cell lymphoma of colon. J Nephropathology 2012;1:202-6.
55. Nickavar A, Sotoudeh K. Treatment and prophylaxis in pediatric urinary tract infection. Int J Prev Med 2011;2:4-9.
56. Kim JK, Kim JH, Lee SC, Kang EW, Chang TI, Moon SJ, et al. Clinical features and outcomes of IgA nephropathy with nephrotic syndrome. Clin J Am Soc Nephrol 2012;7:427-36.
57. Katafuchi R, Ninomiya T, Nagata M, Mitsuiki K, Hirakata H. Validation study of Oxford classification of IgA nephropathy: The significance of extracapillary proliferation. Clin J Am Soc Nephrol 2011;6:2806-13.
58. Kawamura T, Joh K, Okonogi H, Koike K, Utsunomiya Y, Miyazaki Y, et al. A histologic classification of IgA nephropathy for predicting long-term prognosis: Emphasis on end-stage renal disease. J Nephrol 2013;26:350-7.
59. Nasri H. Comment on: Clinical, histopathological and immunofluorescent findings of IgA nephropathy and author's reply. Iran J Immunol 2012;9:266-7.
60. Nasri H, Sajjadieh S, Mardani S, Momeni A, Merikhi A, Madihi Y, et al. Correlation of immunostaining findings with demographic data and variables of Oxford classification in IgA nephropathy. J Nephropathology 2013;2:190-5.
61. Mubarak M. Significance of immunohistochemical findings in Oxford classification of IgA nephropathy: The need for more validation studies. J Nephropathology 2013;2:210-3.